The rand gave back all of Monday’s gains on Tuesday as the euphoria over a possible coronavirus vaccine faded, with investors now cautious about the details regarding its preparation and distribution.

On Monday, news emerged that a vaccine developed by US pharmaceutical giant Pfizer in partnership with BioNTech was showing good results in the testing phase. ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.